학술논문
Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinib
Document Type
Article
Author
Source
In Blood 16 April 2015 125(16):2497-2506
Subject
Language
ISSN
0006-4971